Daiwa Securities Group
PETX

Daiwa Securities Group’s Aratana Therapeutics, Inc. PETX Stock Holding History

Daiwa Securities Group’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-238
Closed -$1K – 1225
2019
Q2 		$1K Hold
238
– – ﹤0.01% 1199
2019
Q1 		$1K Hold
238
– – ﹤0.01% 1180
2018
Q4 		$1K Hold
238
– – ﹤0.01% 1141
2018
Q3 		$1K Hold
238
– – ﹤0.01% 1161
2018
Q2 		$1K Hold
238
– – ﹤0.01% 1182
2018
Q1 		$1K Buy
+238
New +$1.06K ﹤0.01% 1168

Other funds holding PETX

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Daiwa Securities Group's PETX Position: Q3 2019 in Review

Daiwa Securities Group sold out of Aratana Therapeutics, Inc. (PETX) in Q3 2019, closing a stake of 238 shares — an estimated $1K sold.

Daiwa Securities Group first reported a position in PETX in Q1 2018 and held it in 6 quarters. The position peaked at $1K in Q2 2019. 2 funds tracked by Wall St. Rank hold PETX as of Q3 2019.

  • Daiwa Securities Group reported no remaining Aratana Therapeutics, Inc. position as of Q3 2019 after selling out during the quarter.
  • Daiwa Securities Group sold 238 Aratana Therapeutics, Inc. shares in Q3 2019, an estimated $1K.
  • Daiwa Securities Group first reported a position in Aratana Therapeutics, Inc. in Q1 2018 and held it in 6 quarters.
  • Daiwa Securities Group's Aratana Therapeutics, Inc. position peaked at $1K in Q2 2019.
  • 2 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q3 2019.

Based on Daiwa Securities Group's 13F filing for Q3 2019, filed 4 Nov 2019.